Finance

Lists
Why is 4553 down 2,10%?
Dive Deeper
4553:TYO
Towa Pharmaceutical Co Ltd
3 495,00 JP¥
-2,10%
(-75,00) 1D
2-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4553...
Open
3 520 JP¥
High
3 555 JP¥
Low
3 485 JP¥
Mkt. cap
180,05 млд
Avg. vol.
106,56 миң
Volume
97,60 миң
Dividend
2,29%
Quarterly dividend
20 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
20,81
52-wk high
4 490 JP¥
52-wk low
2 764 JP¥
EPS
168 JP¥
Shares outstanding
16,40 млн
No. of employees
5 миң
Open
3 520 JP¥
High
3 555 JP¥
Low
3 485 JP¥
Mkt. cap
180,05 млд
Avg. vol.
106,56 миң
Volume
97,60 миң
Dividend
2,29%
Quarterly dividend
20 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
20,81
52-wk high
4 490 JP¥
52-wk low
2 764 JP¥
EPS
168 JP¥
Shares outstanding
16,40 млн
No. of employees
5 миң
News stories
From web sources and news partners
About Towa Pharmaceutical Co Ltd
CEO-
Employees4,92 миң
Founded1951
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 6-авг.
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
71,38 млд / 72,26 млд
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
65,33 млд
73,59 млд
69,64 млд
71,38 млд
Cost of goods sold
41,80 млд
45,67 млд
45,66 млд
45,28 млд
Cost of revenue
41,80 млд
45,67 млд
45,66 млд
45,28 млд
Research and development expenses
-
-
17,94 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,29 млд
18,87 млд
2,42 млд
19,58 млд
Operating expense
18,29 млд
18,87 млд
20,37 млд
19,58 млд
Total operating expenses
60,09 млд
64,54 млд
66,03 млд
64,86 млд
Operating income
5,24 млд
9,05 млд
3,61 млд
6,52 млд
Other non operating income
1,50 млд
3,31 млд
-4,49 млд
1,83 млд
EBT including unusual items
8,00 млд
12,00 млд
-10,79 млд
7,94 млд
EBT excluding unusual items
6,47 млд
12,01 млд
-1,29 млд
8,14 млд
Income tax expense
2,29 млд
3,13 млд
1,05 млд
2,41 млд
Effective tax rate
28,69%
26,07%
-9,70%
30,37%
Other operating expenses
-
-
-
-
Net income
5,70 млд
8,87 млд
-11,83 млд
5,53 млд
Net profit margin
8,73%
12,05%
-16,99%
7,75%
Earnings per share
-
-
-
-
Interest and investment income
93,00 млн
76,00 млн
89,00 млн
75,00 млн
Interest expense
-609,00 млн
-532,00 млн
-580,00 млн
-628,00 млн
Net interest expenses
-516,00 млн
-456,00 млн
-491,00 млн
-553,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
10,89 млд
14,93 млд
9,66 млд
11,58 млд
Gain or loss from assets sale
32,00 млн
14,00 млн
14,80 млд
-2,00 млн
AI content may include mistakes. Learn more
Google колдонмолору